Please login to the form below
23
Revenue 2017Teva
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.
Changing an organisation’s microfoundations – why capabilities count
At the same time, Sandoz, Teva and other generic companies know that they need to be highly capable in the tendering processes that are quite alien to rare disease markets.
Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined
Teva Pharmaceuticals (Teva) and AbbVie’s Allergan branch have finalised the terms of nationwide settlements to resolve thousands of lawsuits in the US over the marketing of opioid painkillers, the companies ... Throughout the legal proceedings related
The Age of Diversity, Equality and Inclusion
Teva, in its quest to promote greater diversity, underscored the issue by reporting on its website: ‘Only 30% of the participants were over 65 years of age and more than half
FlyPharma Conference Europe 2022 shares the latest supply chain challenges and advice for better industry collaboration
Among the many expert speakers at FlyPharma, Yoram Eshel, former head of global transportation and logistics at Teva Pharmaceuticals, and founder and chief executive officer of Cannabilog, delivered an energetic and
AbbVie’s Allergan reaches proposed $2.37bn agreement to settle US opioid lawsuits
Together with Teva Pharmaceutical’s proposed $4.25bn deal, the total settlement deal could be worth $6.6bn. ... The announcement follows Teva Pharmaceuticals (Teva) reaching a nationwide agreement in principle of up to $4.25bn to settle the lawsuits
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- The increasing value of rare disease trials
- Wrapping up EAU with a Look at Medscape’s Urology Impact
- MHRA to introduce new UK clinical trials framework
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis
- Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children
- Havas Health & You appoints Alex Okada as chief creative officer of Havas Lynx Group
PMHub
The Good Ideas Group
Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
